Pharmaceutical Business review

BTG glucarpidase BLA gets FDA acceptance for review

Glucarpidase is an investigational product which is indicated for the rapid and sustained reduction of toxic methotrexate levels due to impaired renal function.

Additionally, the agency has granted priority review status for glucarpidase BLA.